6IAP

structure of human NKp46 in complex with antibody NKp46-1 and NKp46-4


Sequence Similarity Clusters for the Entities in PDB 6IAP

Entity #1 | Chains: A
Natural cytotoxicity triggering receptor 1 protein, length: 182 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name
100 % 2 2 48660
95 % 2 2 44217
90 % 2 2 42004
70 % 2 2 27627
50 % 2 2 26205
40 % 2 2 23883
30 % 27 40 1267
Entity #2 | Chains: D
Fab NKp46-4 light chain protein, length: 211 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name
100 % 1 1 74998
95 % 1 1 46299
90 % 338 596 4
70 % 1601 2578 2
50 % 2016 3301 2
40 % 2016 3301 2
30 % 4105 6719 1
Entity #3 | Chains: E
Fab NKp46-4 heavy chain protein, length: 217 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name
100 % 1 1 74997
95 % 1 1 61851
90 % 1 1 58220
70 % 1952 3192 1
50 % 2060 3370 1
40 % 2061 3371 1
30 % 4106 6719 1
Entity #4 | Chains: H
Fab NKp46-1 heavy chain protein, length: 220 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name
100 % 1 1 74999
95 % 2 2 44607
90 % 2 2 35655
70 % 1953 3192 1
50 % 2061 3370 1
40 % 2062 3371 1
30 % 4107 6719 1
Entity #5 | Chains: L
Fab NKp46-1 light chain protein, length: 211 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name
100 % 2 2 48661
95 % 9 10 5866
90 % 339 596 4
70 % 1602 2578 2
50 % 2017 3301 2
40 % 2017 3301 2
30 % 4108 6719 1

Instructions

In the table for each entity, view a list of similar sequences by selecting the link associated with the percentage cutoff.



View more detailed documentation on the redundancy reduction and sequence clustering procedure used by RCSB PDB.

You can also use the structure comparison tool to compare any 2 given structures


ACTION - (A) Select for download / view details OR (B) Select two chains for comparison
Rank PDB ID Entity ID Chains Description Details Taxonomy EC Number
1 4NZU 1 L 13PL heavy chain Fab 9606
2 6UCF 1 L N123-VRC34_pI4 light chain 9606
3 5TY6 2 L VRC 315 13-1b02 Fab Light chain 9606
4 6MEE 2 B, D antibody HEPC74 Light Chain 9606
5 6UCE 1 L N123-VRC34_pI3 light chain 9606
6 6TCR 2 L Omalizumab Fab Ser81Arg, Gln83Arg and Leu158Pro light chain mutant Omalizumab Fab Ser81Arg, Gln83Arg and Leu158Pro light chain mutant 9606
7 5UCB 2 L Fab Light Chain 9606
8 5I8C 2 B VRC34.01 Fab light chain 9606
9 5WK2 1 L M116 LIGHT CHAIN 9606
10 4HS6 2 A, L MRCT10.v362 Fab light chain 9606
11 5VSI 2 L CH1/Ckappa Fab light chain 9606
12 6PZG 1 L NA-80 Fab light chain 9606
13 6AZM 1 A, C 580 germline antibody, light chain Fragment: Fab 9606
14 4NWU 2 L APE1551 Ab Fab light chain 9606
15 3HC4 2 L IMMUNOGLOBULIN IGG1 FAB, LIGHT CHAIN 9606
16 6SVL 2 B, E, I, L, M, P Fab_light_chain 9606
17 5OB5 3 L fAb Light chain 9606
18 5UEA 3 B, L Fab Light Chain 9606
19 5TDN 1 A, C anti-HER2 Fab Light Chain 9606
20 3NCJ 1 L Fab15 Mut8 light chain 9606
21 3HC3 2 L IMMUNOGLOBULIN IGG1 FAB, HEAVY CHAIN 9606
22 4NWT 1 L APE1531 Ab Fab light chain 9606
23 3NA9 1 L Fab15 light chain 9606
24 5U6A 1 A Light Chain 9606
25 6K0Y 2 B Antibody Light Chain 9606
26 5UEK 3 L Fab 12E Light Chain 9606
27 3NAA 1 L Fab15 Mut5 light chain 9606
28 5IK3 2 B, D 1E03 Fab fragment light chain 9606
29 5U3D 1 A MEMAB TRASTUZUMAB FAB LIGHT CHAIN I83E 9606
30 6BHZ 2 L, M Trastuzumab Anti-HER2 Fab Light Chain D185A 9606
31 5IT2 2 L light chain 9606
32 6MY4 2 B, L anti-VEGF-A Fab fragment bH1 light chain 9606
33 6DW2 1 A 6078 Fab light chain 9606
34 6BQB 1 L MGG4 Fab light chain 9606
35 4PUB 2 L DX-2930 LIGHT CHAIN 9606
36 6B14 2 L Light chain of Fab BL3-6S97N 10090
37 5VKD 3 L Fab light chain 9606
38 5XHG 1 A, C polypeptide(L) 10090
39 3OAZ 2 K, L Fab 2G12, light chain 9606
40 6MY5 2 B, L anti-VEGF-A Fab fragment bH1 light chain 9606
41 5U4R 2 B, L VRC 315 53-1A09 Fab Light chain 9606
42 5U5F 1 A MEMAB TRASTUZUMAB FAB LIGHT CHAIN I83E 9606
43 6BI2 2 L, M Trastuzumab Anti-HER2 Fab Light Chain 9606
44 6TCO 1 A, L Omalizumab Fab Leu158Pro light chain mutant Omalizumab Fab Leu158Pro light chain mutant 9606
45 4JHA 2 L D25 light chain 9606
46 6B9Z 1 A Trastuzumab Fab light chain 10090
47 5KVL 2 L Humanized 10G4 anti-Leukotriene C4 Immunoglobulin G (IgG) light chain 9606
48 5TDO 1 A, C anti-HER2 Fab Light Chain 9606
49 6U8D 3 L Light chain of Fab HCV2 Light chain of Fab HCV2 9606
50 6PEC 1 L antibody light chain 9544
51 6PE7 2 L FAB Light chain 9606
52 5D6C 1 A, L 4497 antibody IgK (VL and CL) 9606
53 7BZ5 3 L Light chain of B38 9606
54 6NYQ 1 L 1H3 Fab light chain 10090
55 6IAS 2 L Fab NKp46-1 light chain 32630
56 6OBZ 2 B, L Light chain of FluA-20 Fab, Immunoglobulin light chain 9606
57 3P0Y 3 L Fab DL11 light chain 9606
58 6ANA 3 L LL2 Fab Light Chain 10090
59 6AOD 1 A FXIa Antibody FAB Light Chain 9606
60 6TCM 1 L Omalizumab Fab Omalizumab Fab light chain 9606
61 6ELE 2 B, L fAB light chain 9606
62 5UR8 2 B human immunoglobulin gamma, kappa light chain 9606
63 3NAC 1 L Fab15 Mut7 light chain 9606
64 5U5M 1 A MEMAB TRASTUZUMAB, LIGHT CHAIN 9606
65 3EO9 1 L Efalizumab Fab fragment, light chain 9606
66 6N35 1 K, L Fab 2G12 light chain 9606
67 5WUV 1 L light chain 9606
68 2HWZ 1 L Immunoglobulin Fab light chain Humanized mouse antibody MEDI-493 Anti-respiratory syncytial virus antibody 10090
69 5TDP 1 A, C anti-HER2 Fab Light Chain 9606
70 6BAH 1 A Trastuzumab Fab light chain,Immunoglobulin kappa constant 10090
71 6D0X 2 B 1210 Antibody, light chain 9606
72 1L7I 1 L chimera of Fab2C4: "humanized" murine monoclonal antibody The chimera consists of the human Ig and the original murine sequence light chain (residues 1-214) 9606
73 1JPT 1 L immunoglobulin Fab D3h44, light chain Fab fragment 9606
74 6O39 1 A Antibody F2.I Fab, Light chain 9606
75 5XKU 2 B HNIgGA6 light chain 9606
76 6MTT 1 L Antibody VRC46.01 Fb light chain 9606
77 5I18 1 L FAB LIGHT CHAIN 9606
78 3SOB 1 L antibody light chain 9606
79 6B5M 2 L CIS43 Fab Light chain 9606
80 4G6M 3 L light chain of gevokizumab antibody binding fragment 10090
81 4KQ3 1 L CNTO3186 light chain Fab 9606
82 2VXQ 3 L FAB L CHAIN OF THE FAB FRAGMENT COMPOSED OF THE IGE VARIABLE DOMAIN AND IGG CONSTANT DOMAIN 9606
83 4I77 2 L Lebrikizumab light chain Fab 9606
84 5WK3 1 P, R, T, V M116 LIGHT CHAIN 9606
85 4HJG 1 A Trastuzumab light chain 9606
86 3HC0 2 B, L IMMUNOGLOBULIN IGG1 FAB, HEAVY CHAIN 9606
87 5NYX 2 L, N, P LIGHT CHAIN fab light chain 9606
88 5IFA 2 L VRC01c-HuGL2 Fab light chain 9606
89 6ELJ 2 B, L fAB light chain 9606
90 4G6K 2 L light chain of gevokizumab antibody binding fragment 10090
91 1JPS 1 L immunoglobulin Fab D3H44, light chain Fab fragment 9606
92 6CBV 2 L Light Chain, Fab fragment 9606
93 5JW5 2 B, L MEDI8852 Light chain 9606
94 6DCV 1 A, L Light chain of CBTAU27.1 Fab 9606
95 3QWO 1 B, L motavizumab light chain 10090
96 4IOI 1 A Trastuzumab light chain 9606
97 5K8A 1 A, E, L, M humanized Fab Lite chain 10090
98 5VAG 2 B Light chain of antibody m826 9606
99 4RBP 1 K, L Fab 2G12 light chain 9606
100 6DCW 1 L Light chain of CBTAU27.1 Fab 9606
101 6B5N 2 L CIS43 Fab Light chain 9606
102 3OAY 1 K, L Fab 2G12, light chain 9606
103 6AND 3 L Pinatuzumab Fab light chain 9606
104 5JRP 1 L marberg virus monoclonal antibody MR78 Fab light chain 9606
105 5F7E 2 L Fab light chain 9606
106 1T3F 1 A Huzaf antibody light chain The source is engineered human constant and framework regions with CDRs from mouse 9606
107 5FHA 2 L Antibody 114 Fab light chain 9606
108 5UMN 3 D, F Antibody C05, light chain 9606
109 4X7S 2 L Ig kappa chain C region residues 23-236 9606
110 1S3K 1 L HU3S193 Fab fragment, light chain murine complementarity determining regions grafted onto human framework and constant sequences 10090
111 3QPQ 1 C, E, I, L C1068 light chain 10090
112 6PHB 2 A, C 2530 Antibody Fab, Light Chain 9606
113 6MXR 2 B, L anti-VEGF-A Fab fragment bH1 light chain 9606
114 6ELL 2 B, L fAB light chain 9606
115 2HFF 1 A, L CB2 Fab, light chain 9606
116 4M7K 1 L 10H10 light chain SEE REMARK 999 10090
117 1VGE 1 L TR1.9 FAB FAB FRAGMENT OF A HUMAN IGG1 KAPPA AUTOANTIBODY 9606
118 6MXS 2 B, L anti-VEGF-A Fab fragment bH1 light chain 9606
119 5I1L 1 A, L FAB LIGHT CHAIN 9606
120 5GGV 1 L light chain 9606
121 3L5X 1 L H2L6 LIGHT CHAIN 9606
122 5BJZ 3 H, L Synthetic antibody, Fab fragment, Light Chain 9606
123 2R8S 2 L Fab light chain 10090
124 4HKZ 1 A Trastuzumab light chain 9606
125 6DB8 3 L Fab-Light chain 32630
126 6DDR 1 A Anti-MICA Fab fragment light chain clone 13A9 10090
127 6MEH 3 L antibody HEPC74 Light Chain 9606
128 6O23 2 B, D 2243 kappa light chain 9606
129 3OAU 2 L Fab 2G12, light chain 9606
130 5WEQ 1 A MR78 mutant light chain 9606
131 6TCQ 2 L Omalizumab Fab Ser81Arg and Gln83Arg light chain mutant Omalizumab Fab Ser81Arg and Gln83Arg light chain mutant 9606
132 4ZYK 2 B, L AM14 light chain 9606
133 6DWA 1 A, L 4497 Fab Light Chain 9606
134 5E94 1 A, C Antibody Fab fragment light chain 10090
135 6MED 2 B, D, I antibody HEPC3 Light Chain 9606
136 1CE1 1 L PROTEIN (CAMPATH-1H:LIGHT CHAIN) FAB 9606
137 6ME1 2 B, D VRC34.01 Fab light chain 9606
138 5ITB 2 L anti-RSV F Fab 14N4 Light chain 9606
139 4KMT 1 L light chain O12/KAPPA Fab 9606
140 6U3Z 2 B, D V20_5A4 Light Chain Fab 9544
141 6CW3 2 B, D antibody light chain 9606
142 6BTJ 2 B, L Light chain of H7.5 Fab 9606
143 6BLI 2 B, E, H, K CB002.5 Fab Light Chain 9606
144 4XTR 3 D, F Antibody Light chain 32630
145 1RZ7 1 L Fab 48d light chain 9606
146 1RZG 2 B, D Fab 412d heavy chain 9606
147 5EA0 2 L Light chain of antibody 7968 Fab fragment 9606
148 3PGF 3 L SAB Light Chain 9606
149 6B9Y 1 A Trastuzumab Fab light chain 9606
150 2QQN 3 L Antibody light chain 9606
151 6MSY 1 L Fab 2G12, light chain 9606
152 3L5W 1 A, L C836 LIGHT CHAIN CHIMERIC MOLECULE OF MOUSE VARIABLE DOMAIN AND HUMAN CONSTANT DOMAIN 10090
153 6BAE 1 A Trastuzumab Fab light chain 10090
154 4OGY 3 L, N DX-2930 LIGHT CHAIN 9606
155 2CMR 3 L D5 9606
156 5ZV3 3 L Light chain (kappa) of antibody CBTAU28.1 9606
157 4R4B 1 A, C, E, L FAB 2.2C LIGHT CHAIN 9606
158 5CZX 3 D, L 20358 Fab light chain 9606
159 6BI0 2 L, M Trastuzumab anti-HER2 Fab Light Chain 9606
160 3GRW 2 L Fab light chain 9606
161 6B3K 2 L Light chain of Fab BL3-6 10090
162 5I1D 1 A, L FAB LIGHT CHAIN 9606
163 5VKK 2 B, L Epratuzumab Fab Light Chain 10090
164 6AYZ 2 C, D Fab Light Chain 9606
165 6O3A 1 A Antibody F7.B Fab, Light chain 9606
166 1UJ3 1 A IgG Fab light chain anti-tissue-factor antibody hATR-5 Fab 9606
167 4LKC 1 A Fab fragment of PCSK9 antibody 9606
168 4KZD 2 L BL3-6 Fab antibody, light chain 10090
169 4CNI 2 B, L OLOKIZUMAB LIGHT CHAIN, FAB PORTION FAB PORTION 9606
170 6O1F 4 L Light Chain hu31A.v11 9606
171 4XH2 2 B, D, F, I, K, L Fab Light Chain 9606
172 5IES 2 L VRC01cHuGL2 Fab light chain 9606
173 6OCB 2 L Light chain of FluA-20 Fab 9606
174 6RCS 2 B R5.016 light chain 9606
175 3S34 1 L 1121B Fab light chain 10090
176 6B6Z 1 A, C Apo Fab Light Chain 9606
177 6EMJ 2 B, L fAb light chain 9606
178 5W1G 2 L CR1-07 Fab light chain 9606
179 6CNR 1 L Aducanumab light chain 9606
180 2AJ3 1 A, C, E Fab m18, Light Chain 9606
181 6PLK 2 L, M ZIKV-116 light chain 9606
182 6OKM 2 L Fab 3C8 light chain 9606
183 4NRX 3 B, E, L m66 Light Chain 9606
184 3O2D 1 L ibalizumab light chain 10090
185 6DB9 3 L Fab-Light-Chain 32630
186 3HI6 3 L, Y light chain of Fab fragment of AL-57 against alpha L I domain 9606
187 5O14 3 D, L Fab 1A12 Light Chain 9606
188 4ZFG 3 L Fragment antigen binding 5A12 light chain 9606
189 6B5O 2 L CIS43 Fab Light chain 9606
190 2R0L 1 L antibody light chain 32630
191 5BK1 2 D, L Synthetic antibody, Fab fragment, Light Chain 9606
192 6N32 1 L, M Fab 2G12 light chain 9606
193 6TYB 4 L NEUTRALIZING ANTIBODY ITS90.03 FAB LIGHT CHAIN 9544
194 6DWC 1 A, L 4497 Fab Light Chain 9606
195 6VBP 1 B, D, I, L DH815 light chain 9606
196 5VR9 2 B, L CH1/Ckappa Fab light chain 9606
197 5VZ1 1 A, C Apo Antibody Fab Light Chain 9606
198 5OD8 2 B B2 Fab fragment - Light chain 9606
199 3KR3 3 L antibody-Fab (light chain) 9606
200 6DZN 1 L Antibody ADI-15878, light chain 9606
201 5GGU 2 B, L light chain 9606
202 5KW9 3 L IgA Light chain 9606
203 6TCN 1 A, L Omalizumab Fab Omalizumab Fab light chain 9606
204 6XXV 2 B, E Antibody C57, Light Chain 9606
205 5W2B 2 L Fab Light Chain 9606
206 6E4X 2 Y S5V2-29 light chain 9606
207 3C08 1 L Matuzumab Fab Light chain Human/mouse chimeric derivative of mouse monoclonal antibody 425 10090
208 6AXL 1 B, C Fab317 light chains 9606
209 6HIG 2 L Light Chain 10090
210 6CXG 1 K, L anti-HIV-1 Fab 2G12 light chain 9606
211 6CO3 1 L Fab light chain 9606
212 4NRZ 2 B, L M66.6 LIGHT CHAIN Fab Light Chain 9606
213 3BN9 2 C, E E2 Fab Light Chain 9606
214 6DZR 2 L h38c2 light chain 9606
215 6U9U 2 L GM9_TH8seq732127 FAB light chain 9606
216 3L95 1 A, L anti-NRR1 fab fragment light chain 9606
217 4OGX 3 L DX-2930 LIGHT CHAIN 9606
218 4KZE 2 L BL3-6 Fab antibody, light chain 10090
219 6NHA 3 L SYNT001-Fab light chain 9606
220 6MU3 1 K, L Fab 2G12, light chain 9606
221 4XVU 3 D, F, J, L Antibody light chain 32630
222 5B71 1 A, C SKY59 Fab light chain 9606
223 6BF4 3 C, L VRC-PG05 Fab light chain 9606
224 3NAB 1 L Fab15 Mut6 light chain 9606
225 4Q9Q 2 L Fab BL3-6, LIGHT CHAIN 10090
226 4WV1 3 A, D Fab light chain 9606
227 5EII 2 B, L Fab Light Chain 9606
228 4FNL 2 L, M Antibody C05, Light Chain 9606
229 4UB0 2 L IgG1, light chain 9606
230 1FVD 1 A, C IGG1-KAPPA 4D5 FAB (LIGHT CHAIN) 9606
231 1BJ1 1 J, L Fab fragment, light chain HUMANIZED VERSION OF A MONOCLONAL MURINE ANTI-VEGF ANTIBODY 10090
232 6BFT 1 B, L Avastin Light Chain Fab fragment mutant 9606
233 3IDX 3 L Fab b13 light chain 9606
234 5IF0 2 B, L VRC01c-HuGL2 Fab light chain 9606
235 5K9Q 4 I, K, L, T, V, Y 16.a.26 Light chain 9606
236 6B5L 2 L CIS43 Fab Light Chain 9606
237 4ZD3 2 L 679-14-14E06 Fab fragment light chain 9606
238 5VEB 2 B, L anti-CDH6 Fab light chain 9606
239 6N81 2 D, L A1227 Fab light chain 9606
240 5E08 2 L Fab Light Chain 9606
241 6AZ2 3 E, F Fab Light Chain 9606
242 1CZ8 2 L, X LIGHT CHAIN OF NEUTRALIZING ANTIBODY MUTATED FORM OF A HUMANIZED MURINE ANTIBODY LIGHT CHAIN 10090
243 4XAK 3 E, L Light chain of neutralizing antibody m336 9606
244 5JQ6 3 L Tefibazumab FAB FRAGMENT LIGHT CHAIN 10090
245 3HR5 1 A, L, P, Q Fab h47H4 light chain 10090
246 6AL4 1 A, C, E B43 LIGHT CHAIN 9606
247 4EDW 2 L tanezumab Fab light chain 9606
248 1FVE 1 A, C IGG1-KAPPA 4D5 FAB (LIGHT CHAIN) 9606
249 6YLA 3 C, L Light chain 9606
250 4NM4 1 L, M Antibody CR8043, Light Chain 9606
251 2H9G 1 A, L Fab BdF1, light chain Fab fragment 9606
252 4G7V 2 L fragment antibody light chain 9606
253 4HFW 1 A, L 6-26 Fab Light chain 9606
254 3L7E 1 A, L C836 LIGHT CHAIN CHIMERIC MOLECULE OF MOUSE VARIABLE DOMAIN AND HUMAN CONSTANT DOMAIN 10090
255 2XRA 3 L HK20, HUMAN MONOCLONAL ANTIBODY LIGHT CHAIN 9606
256 4LIQ 3 L Fab fragment RG7155 light chain Humanized Version of a monoclonal murine. 10090
257 5JO4 4 D G6 Fab Light Chain 9606
258 3INU 2 L, N KZ52 antibody fragment light chain 9606
259 5EU7 3 C, D FAB light chain 9606
260 1DFB 1 L IGG1-KAPPA 3D6 FAB (LIGHT CHAIN) 9606
261 6XC3 2 L CR3022 light chain 9606
262 6XC3 3 A CC12.1 light chain 9606
263 1AD0 1 A, C ANTIBODY A5B7 (LIGHT CHAIN) FAB FRAGMENT 9606
264 4U6V 2 L, M Fab, antigen binding fragment, light chain 9606
265 6X5M 1 L, l Light chain Fab BL-3 6 10090
266 2XA8 2 L OMALIZUMAB LIGHT CHAIN 9606
267 3EYV 1 A, L hu3S193 Fab, light chain 10090
268 6Q20 2 L 1E01 Fab kappa light chain 9606
269 5IJK 3 C, D 1E03 Fab fragment light chain 9606
270 3BDY 2 L Fab Fragment -Light Chain 9606
271 5I8E 2 B, D VRC34.01 Fab light chain 9606
272 3FZU 1 D, L immunoglobulin IgG1 Fab, light chain 9606
273 5UIX 2 L DH576 Fab light chain 9606
274 3K2U 4 L Antibody, Fab fragment, Light Chain 9606
275 6TCP 1 A, C, E, L Omalizumab Fab Leu158Pro light chain mutant Omalizumab Fab Leu158Pro light chain mutant 9606
276 5VSH 2 B, D, F, L CH1/Clambda Fab light chain 9606
277 1PG7 2 L, M humanized antibody D3H44 antigen-binding fragment 10090
278 2HFG 1 L CB3s Fab light chain (kappa) 9606
279 3GKW 2 L Light chain of the antibody Nimotuzumab 9606
280 3JWD 3 L, O FAB 48D LIGHT CHAIN 9606
281 5ZIA 2 B, E, I, L, M, P Light chain (kappa) of CBTAU-24.1 antibody 9606
282 4JQI 3 L Fab30 light chain 10090
283 6B0H 3 A, C 1262 antibody, light chain 9606
284 6U8C 2 C, L Antibody light chain Fab 9606
285 3SKJ 1 L, M Antibody, light chain 9606
286 3U30 2 B, E Light chain Fab 9606
287 6ULE 2 B, D 2541 Antibody, light chain 9606
288 6MFJ 2 B, L DH677.3 Fab light chain 9606
289 5HYS 2 B, D, F, L Uncharacterized protein 9606
290 3L7F 1 A, D, L H2L6 LIGHT CHAIN 9606
291 5I15 1 L FAB LIGHT CHAIN 9606
292 2FJF 1 A, C, E, G, J, L, M, O, Q, S, U, W Light Chain of a VEGF binding Antibody 9606
293 6U8K 3 E, G, L Light chain of Fab HCV3 Light chain of Fab HCV3 9606
294 5I1E 1 L FAB LIGHT CHAIN 9606
295 4JLR 2 B, L Motavizumab Fab light chain 9606
296 2QQK 3 L Antibody Light Chain 9606
297 4J1U 1 A, C, E antibody 93F3 Light chain 10090
298 4RRP 1 A, B, C, D, E, F Fab antibody, light chain 9606
299 5SX5 1 K, L Panitumumab Fab Light Chain 9606
300 4XGZ 2 B, D, F, I, K, L, N, P, R, T, V, X FAB LIGHT CHAIN 9606
301 1N8Z 1 A Herceptin Fab (antibody) - light chain 10090
302 4OAW 1 A, C Light chain of Fab fragment of anti-HIV1 gp120 V2 mAb 2158 9606
303 5BK2 3 D, L sAB Light Chain 9606
304 1TZH 2 A, L Fab YADS1 Light Chain 10090
305 5O1R 3 L, M Uncharacterized protein 9606
306 4JZJ 3 B, L Fab Light Chain 10090
307 5BO1 3 L, M Fab light chain 9606
308 6FOE 2 B, L Fab BaxB01 light chain engineered Fab light chain binds oxidized macrophage migration inhibitory factor (MIF) 9606
309 6Z2M 3 C, L CR3022 antibody 9606
310 4M6O 1 L CNTO7309 light chain 9606
311 5LSP 3 L, T 107_A07 Fab light chain 9606
312 6MWN 3 D, L Fab HAVx Light Chain 9606
313 4DVR 2 L Fab 48d Light chain 9606
314 6PI7 2 B, E Uncharacterized protein 9606
315 5BK3 1 B, D, F, L 580 Antibody, light chain 9606
316 6HXW 3 D, L IPH53 light chain 32630
317 4XWO 3 D, F, J, L, P, R, V, X Antibody light chain 32630
318 4ZFF 2 B, L Fragment antigen binding (Fab) 5A12 Light chain 9606
319 3HI5 2 L light chain of Fab fragment of AL-57 against alpha L I domain 9606
320 6BGT 2 A Herceptin light chain mutant 9606
321 5FUZ 2 L 645 FAB, LIGHT CHAIN 9606
322 3DVG 1 A Human IgG1 fab fragment light chain 9606
323 6ZCZ 4 L EY6A light chain 9606
324 4HS8 3 L antibody hu5B3.v2 Fab light chain 9606
325 1B6D 1 A, B IMMUNOGLOBULIN IMMUNOGLOBULIN LIGHT-CHAIN DIMER 9606
326 3NFS 1 L Heavy chain of Fab fragment of daclizumab 9606
327 2FGW 1 L H52 FAB (LIGHT CHAIN) 9606
328 1B2W 1 L PROTEIN (ANTIBODY (LIGHT CHAIN)) V DOMAIN AND C DOMAIN 10090
329 2FJG 2 A, L Fab light chain 9606
330 4DKF 3 L, M FAb2 Light Chain 9606
331 5TLK 3 C, G H2191 LIGHT CHAIN 10090
332 6OGX 2 D Fab1 Light Chain 9606
333 6OGX 5 L Fab2 light chain 9606
334 1HEZ 1 A, C KAPPA LIGHT CHAIN OF IG 1-214 9606
335 6MEJ 5 L antibody HEPC3 Light Chain 9606
336 3EFD 1 L FabL 10090
337 4LF3 1 A, D Fab heavy chain 10090
338 6IAP 2 D Fab NKp46-4 light chain 32630
339 6IAP 5 L Fab NKp46-1 light chain 32630
340 5K59 4 F, L Fab light chain 9606
341 6MUB 1 K, L Fab 2G12, light chain 9606
342 6BFQ 2 B, D, F, L Fab Light Chain 9606
343 6PZF 2 E, L NA-63 Fab light chain 9606
344 5KN5 2 B, E Epiregulin Antibody LY3016859 Fab Light Chain 9606
345 6O3B 1 A, E Antibody Fab F6, Light chain 9606
346 5F3H 2 B, D, F, H humanized RK35 antibody light chain 10090
347 4LEO 2 B RG7116 Fab light chain 10090
348 4G7Y 2 L Fragment antibody light chain 9606
349 4PY8 4 J antibody 3.1 light chain Fab 9606
350 3DVN 1 A, L Human IgG1 fab fragment light chain 9606
351 3IXT 1 B, L Motavizumab Fab light chain 10090
352 3UC0 3 L, M Light chain, monoclonal antibody 5H2 Fab 9598
353 1BBJ 1 A, L IGG4-KAPPA B72.3 FAB (LIGHT CHAIN) 10090
354 6U85 2 L antibody Fab Light chain 9606
355 5I1I 1 L FAB LIGHT CHAIN 9606
356 4NNP 3 L, Y Light chain of antagonistic fab fragment 9606
357 4ERS 1 L Fab light chain 9606
358 1DEE 1 A, C, E IGM RF 2A2 FAB LIGHT CHAIN 9606
359 2WUC 5 L FAB FRAGMENT FAB40.DELTATRP LIGHT CHAIN 9606
360 3SQO 3 L J16 Light chain 9606
361 4K3J 4 L Onartuzumab Fab light chain 10090
362 6PE8 2 B, L FAB Light chain 9606
363 6CYF 2 C, E, L, T IgG1 antibody, kappa light chain 9606
364 6MNF 1 K, L Fab 2G12, light chain 9606
365 4PY7 2 B, J antibody 3.1 light chain Fab 9606
366 6AL5 2 L B43 LIGHT CHAIN 9606
367 4K8R 3 C Fab1, light chain 9606
368 6P3R 2 B, D Human Fab H5.31 light chain 9606
369 6HHC 1 L FXIA ANTIBODY FAB LIGHT CHAIN 9606
370 6ML8 4 L C05 antibody Fab light chain 9606
371 1TZI 1 A Fab YADS2 Light Chain 10090
372 4KUZ 1 L antibody 4A5 light chain Fab (mouse variable domain, human constant domain) 10090
373 4X7T 2 B, L Omalizumab-Fab Light chain 9606
374 4YK4 1 B, Y 641 I-9 VLCL antibody 9606
375 2QSC 1 L Fab F425-B4e8, Light chain Light chain 9606
376 1MHP 3 L, Y FAB FRAGMENT, light chain 10090
377 4N9G 2 B, F, L, N Antibody 17HD9, Light Chain 9544
378 6MEI 3 L antibody HEPC3 Light Chain 9606
379 3R1G 3 L FAB of YW412.8.31 antibody light chain 9606
380 2QQL 3 L Antibody Light Chain 9606
381 4MXV 2 E, L, X anti-Lymphotoxin alpha antibody light chain Fab 9606
382 5SX4 1 I, L Panitumumab Fab Light Chain 9606
383 3WD5 2 L Adalimumab Light Chain 9606
384 3EOA 1 A, L Efalizumab Fab fragment, light chain 9606
385 5GZO 3 D, L Antibody light chain 9606
386 6W16 3 L 458 Fab light chain 9606
387 2WUB 4 L, Q FAB FRAGMENT FAB40.DELTATRP LIGHT CHAIN 9606
388 4KY1 1 L IMMUNOGLOBULIN IGG1 FAB, LIGHT CHAIN muHP1/2 CDRs + human kappa B3 germline VL framework 9606
389 7C01 3 D, L CB6 light chain 9606
390 6XC7 3 L CR3022 light chain 9606
391 4FP8 3 L, M, N, O Antibody C05, light chain 9606
392 6R2S 1 A Antibody DB9 light chain 9606
393 6I8S 3 I, J, K, L LIGHT CHAIN OF FAB FRAGMENT FROM AN PAI-1 ANTIBODY FAB FRAGMENT 9606
394 6CW2 4 B antibody light chain 9606
395 3BE1 3 L Fab Fragment-Light Chain 9606
396 2FJH 2 A, L Fab fragment light chain 9606
397 5XEZ 3 D, L Antibody, mAb1, light chain 9606
398 3P0V 1 L, M Fab DL11 light chain 9606
399 2OQJ 1 A, D, G, J Fab 2G12 light chain 9606
400 6OEL 5 L engineered Fab light chain 9606
401 6X5N 1 L, l Light chain Fab BL-3 6 10090
402 6UTE 2 B, D, F, H, J Z032 Fab light chain 9606
403 5VIG 2 B, L Fab light chain 9606
404 3HMX 3 L USTEKINUMAB FAB LIGHT CHAIN 9606
405 6I04 3 D, L Fab light chain 9606
406 5VYF 1 A, L Antibody light chain 10090
407 4K7P 1 X antibody rhumAb6 Fab fragment light chain Fab rhumAb6 9606
408 4K7P 4 L antibody 10C4 Fab fragment light chain 10090
409 5WUX 2 B, D, L light 9606
410 3OB0 1 K, L Fab 2G12, light chain Fab 9606
411 6MFP 4 D, L DH677.3 Fab light chain 9606
412 1T04 1 A, C Huzaf Antibody Light Chain The source is engineered human constant and framework regions with CDRs from mouse. 9606
413 6GK7 1 L HUMAN FAB ANTIBODY FRAGMENT OF CBTAU-27.1(S31Y,T100I) FAB ANTIBODY FRAGMENT 9606
414 3ZTN 4 L FI6V3 ANTIBODY LIGHT CHAIN 9606
415 4I18 1 B, L antibody light chain Fab 10090
416 4Q9R 2 L Fab BL3-6, LIGHT CHAIN 10090
417 3IDY 3 C, L Fab b13 light chain 9606
418 3IVK 1 B, L Fab light chain man 10090
419 5I19 1 L FAB LIGHT CHAIN 9606
420 5TH9 1 L, M, N GS-5745 Fab light chain 9986
421 6OKN 2 B, D Fab 1A7 light chain 9606
422 6OC3 2 B, D Light chain of FluA-20 Fab 9606
423 6NZ7 4 I, L 429 B01 FAB light chain 9606
424 5X8L 2 K, L, M, N, O atezolizumab light chain 9606
425 5UDC 2 C, G, L MEDI8897 Fab Light Chain 9606
426 6GK8 2 L HUMAN FAB ANTIBODY FRAGMENT OF CBTAU-28.1(S32R;E35K) FAB ANTIBODY FRAGMENT 9606
427 5FEC 2 B, L germline 3BNC60 light chain 9606
428 1RZI 1 A, C, E, G, I, K, M, O Fab 47e light chain 9606
429 2R56 2 L, M IgE Fab Fragment, light chain 9606
430 1ZA6 1 A, C, E, G IGG Light chain 9606
431 4ZS6 1 D, L fab Light Chain 9606
432 4Z5R 2 A, J, L, P, R, T, V, Y anti-IFN-a antibody rontalizumab light chain 9606
433 6APB 3 L ADI-14359 Fab Light Chain 9606
434 5CD3 2 B, D, F, H DRVIA7 Light Chain 9606
435 6D01 2 B, D, F, H 1210 Antibody, Light chain 9606
436 6Q23 3 F, I, K, L 1G01 Fab kappa light chain 9606
437 5CZV 3 L Fab 20350 light chain 9606
438 5XF1 3 D, L Antibody mAb1 Light chain 9606
439 4P59 3 L MOR09825 Fab fragment light chain 9606
440 5XXY 2 L light chain of atezolizumab fab 9606
441 5CJO 3 L FAB light chain 10090
442 4LMQ 3 I, L Stromal cell-derived factor 1 9606
443 3N85 2 L Fab37 Light Chain 9606
444 6XC2 2 L, Y CC12.1 light chain 9606
445 3G6J 3 E, G Fab light chain 9606
446 5GJT 3 L light chain of human neutralizing antibody 3E1 light chain of neutralizing antibody 3E1 9606
447 6MH2 1 A, C Herceptin Fab arm light chain 9606
448 6K7O 3 C, E, G, L h128-3 Fab light chain 9606
449 3HMW 1 L USTEKINUMAB FAB LIGHT CHAIN 9606
450 5O4G 2 A MF3958 FAB light chain 9606
451 6PE9 2 B, D, F, L, M FAB Light chain 9606
452 2QAD 3 C, G anti-HIV-1 antibody 412d light chain FAB, ANTIGEN-BINDING FRAGMENT 9606
453 4DKE 3 L, M FAb1.1 Light Chain 9606
454 6W41 2 L CR3022 Fab light chain 9606
455 5VIC 2 L Fab light chain 9606
456 6MEK 3 D, L HEPC3 Light Chain 9606
457 3NFP 2 B, L Light chain of Fab fragment of daclizumab 9606
458 1BEY 1 L CAMPATH-1H ANTIBODY FAB FRAGMENT 9606
459 5GJS 3 L light chain of human neutralizing antibody 3E1 9606
460 6Q1Z 2 C, L 1G04 Fab kappa light chain 9606
461 4NRY 1 B, L m66 Heavy Chain 9606
462 6OE4 2 C, F CR9501 Fab Light Chain 9606
463 6N2X 1 K, L Fab 2G12 light chain 9606
464 3S37 1 L 1121B Fab light chain 10090
465 5XHF 1 A, C polypeptide (L chain) 10090
466 5VL7 4 L Fab33 light chain 9606
467 1PKQ 1 A, F (8-18C5) chimeric Fab, light chain 10090
468 6P8N 3 D, L P-p1f1 Light Chain 10090
469 6DEZ 1 A, L Anti-phosphotyrosine antibody PY20-4D5 light chain 32630
470 1S78 2 C, E Pertuzumab Fab light chain 10090
471 4NYL 1 B, D, F, L Adalimumab Light Chain 9606
472 5D1Z 1 A, H Y10 Light Chain 9606
473 5D1Z 3 C, E D4-10 Light Chain 9606
474 4XHJ 3 C, G Fab-RC light chain 9606
475 5O4O 1 A MF3178 FAB light chain 9606
476 5HJ3 4 B, F, J, N KZ52 Antibody Fragment 9606
477 5D1Q 1 A D2-06 Light Chain 9606
478 1ZA3 1 A, L Fab-YSd1 light chain Fab light chain 9606
479 3UAJ 3 D, L Light chain, monoclonal antibody 5H2 Fab 9598
480 3C09 1 B, L Matuzumab Fab Light chain Human/mouse chimeric derivative of mouse monoclonal antibody 425 10090
481 5XHV 3 L, Q S40 light chain 9606
482 6YZ7 3 CCC, LLL Antibody light chain 9606
483 4IOF 3 D, F Fab-bound IDE, light chain 10090
484 6S3D 2 B, D, F, L Light Chain 9606
485 5FUO 3 L FAB LIGHT CHAIN 9606
486 4JHW 2 L D25 light chain 9606
487 4HG4 4 K, M, O, Q, S, U, W, Y, z Fab 2G1 light chain 9606
488 6CXL 1 K, L anti-HIV-1 Fab 2G12 light chain 9606
489 3ZTJ 4 H, J, L FI6V3 ANTIBODY LIGHT CHAIN 9606
490 7BXA 3 C, L light chain 9606
491 4M1C 3 D, F Fab-bound IDE, light chain 9606
492 5UQY 3 C, G, K, O MR78 Fab light chain 9606
493 6D0U 3 D, F, I, L Antibody C05, light chain 9606
494 2JIX 1 A, G, L ABT-007 FAB FRAGMENT 9606
495 3ULV 2 L Fab15 light chain 9606
496 3ULV 6 E Fab1068 light chain 9606
497 6W7Y 2 B, L CR3022 Light chain 9606
498 4M7L 2 L 10H10 light chain SEE REMARK 999 10090
499 6ZER 3 C, G, L light chain 9606
500 6OUS 4 N, P, R, T, V, X RB1 Fab Light chain 9606
501 6UTA 2 B, L Z004 iGL Fab light chain 9606
502 6P8M 3 L P-p3b3 Light Chain 10090
503 4MXW 5 L, V anti-Lymphotoxin alpha antibody light chain Fab 9606
504 5UOE 3 L, N, Q, T, W FAB light chain 9606
505 5VL3 3 B, D, F, L Epratuzumab Fab Light Chain 10090
506 5JW3 4 L MEDI8852 light chain 9606
507 6D11 2 B, D 1450 Antibody, Light chain 9606
508 3S36 1 L 1121B light chain 10090
509 5CWS 1 A, G sAB-158 Fab Light Chain 9606
510 5I5K 3 L, Y Eculizumab light chain (variable domain) 9606
511 2R0K 2 L antibody light chain of Fab58 9606
512 3CSY 2 B, D, F, H Fab KZ52 light chain light chain 9606
513 5C8J 2 B, D, F, H Antibody fragment, light chain OBTAINED BY PHAGE DISPLAY FROM A LIBRARY OF HUMAN IGG. ANTIBODY FRAGMENT; THE CDRS ARE COMPLETELY SYNTHETIC 9606
514 4R4F 2 L Antibody 2.2c LIGHT CHAIN 9606
515 4G80 3 B, D, F, H fragment antibody light chain 9606
516 3JWO 3 L FAB 48D LIGHT CHAIN 9606
517 5CD5 3 D DRVIA7 Fab Light Chain 9606
518 3P11 2 L Fab DL11 light chain 9606
519 3ULU 2 L Fab15 light chain 9606
520 3ULU 6 E Fab1068 light chain 9606
521 5W1K 1 A, F, K, S CR1-28 Fab light chain 9606
522 4XI5 3 C Fab-94 light chain 9606
523 5WOB 4 J, L, N, P, R, T, V, X IDE-bound Fab light chain 60742
524 3EOB 1 A, L Efalizumab Fab fragment, light chain 9606
525 6EAY 1 L CA45 light chain 9541
526 5G64 3 L, M FAB FRAGMENT LIGHT CHAIN, RESIDUES 1-218 9606
527 4NM8 3 L, M, N Antibody CR8043, Light Chain 9606
528 5W1M 1 A, C, E, G CR1-07 Fab light chain 9606
529 6RCV 4 D, I R5.016 light chain 9606
530 5JW4 4 N, P, T, V, X MEDI8852 light chain 9606
531 5JW4 6 R MEDI8852 light chain 9606
532 2QR0 1 A, E, G, K, M, Q, S, W Fab-Fragment Light Chain 9606
533 5UDD 3 P, Q, R, S, T, U MEDI8897 Fab Light Chain 9606
534 5J3D 2 B, D, L 14N4 light chain 9606
535 4R4N 3 D, G, K, L, O, R, U, X Antibody 2.2c LIGHT CHAIN 9606
536 3EFF 1 A, C FAB 10090
537 3PJS 1 A, C FAB light chain 10090
538 6OE5 3 C Motavizumab Fab Light Chain 10090
539 6OE5 5 L CR9501 Fab Light Chain 9606
540 6MAM 2 B, D, F ADI-15946 Fab Light Chain 9606
541 5O7P 2 A MF3178 FAB light chain 9606
542 4ZYP 3 L, M, O Motavizumab antibody light chain 10090
543 4ZYP 5 E, G, I AM14 antibody light chain 9606
544 6P3S 2 B, D, G, J, N, Q, T, W Human Fab H5.28 light chain 9606
545 6RCU 4 D R5.016 light chain 9606
546 5DWU 4 L Fab - Light Chain 9606
547 5V2A 3 L Light chain (kappa) of H7.167 antibody Fab 9606
548 6EA7 4 L, N, R ADI-15878 Fab Light Chain 9606
549 5I8H 5 F, H VRC34.01 Fab light chain 9606
550 4FQR 4 b, d, f, h, j, l, n, p, r, t, v, x Broadly neutralizing antibody C05, light chain 9606
551 4R4H 3 L Antibody 2.2c, Light chain 9606
552 6EA5 4 L, N, R ADI-15878 Fab Light Chain 9606
553 6YM0 3 L light chain 9606
554 5FHC 5 L Antibody 114 Fab light chain 9606
555 4XMN 6 L Antibody 87 light chain 32630
556 4XMM 8 L Antibody 57 light chain 9606
557 4NHH 1 F, G, K, L, P, Q 2G12 IgG dimer light chain 9606
558 4NHG 2 B, C, F, G, K, L 2G12 IgG dimer light chain 9606
559 6ZFO 3 C, L EY6A light chain 9606
560 6ZDH 3 F, I, L EY6A light chain 9606
561 6XDG 2 D REGN10933 antibody Fab fragment light chain 10090
562 6YOR 3 C, L IgG L chain 9606
563 6Y9B 2 L, M, N Fab120.545 light chain 10090
564 6TKO 4 L Fab30 light chain 279974
565 6USF 4 L, M Fab light chain 9606
566 6UKJ 3 L Fab Light Chain 9606
567 6SNH 3 L 6AG9 Fab light chain 32630
568 6SNI 3 L 6AG9-Fab light chain 32630
569 6U1N 4 L Fab30 light chain 9606
570 6U02 2 C, F, I, L Fab-63 Light Chain 9606
571 6PZZ 2 E, G, J, L NA-80 fragment antibody light chain 9606
572 6PWC 5 L Fab30 light chain 32630
573 6PCI 3 K, L, M rEBOV-548 Fab light chain 9606
574 6OZC 3 D, L, M, N, Q, R 2G12 Fab light chain 9606
575 6OT0 5 L Fab light chain 10090
576 6OGE 2 B Pertuzumab FAB LIGHT CHAIN 9606
577 6OGE 4 D Trastuzumab FAB LIGHT CHAIN 9606
578 6QD8 1 L, Y, Z Light chain 9606
579 6NI2 4 L Fab30 Light Chain 32630
580 6NC3 4 L, T, U, V, W, X Monoclonal antibody VRC34.01 fragment antigen binding light chain 9606
581 6MLM 4 G, I, L Light chain Fv of H7.5 Fab 9606
582 6MJZ 3 L PIA174 Fab Light chain 9606
583 6E5P 1 1, 4, K, L, Q, T 2G12 Light chain 9606
584 6E1K 2 C, E cat06 light chain 9606
585 6CMO 5 L Fab light chain 32630
586 6BF7 3 D, F Fab H11-E light chain 10090
587 6BF9 3 D, F Fab H11-E light chain 10090
588 6B7Z 3 D, F FAB H11 light chain 10090
589 6B70 3 D, F FAB H11-E light chain 10090
590 3J70 2 B, N, S monoclonal antibody 17b heavy chain 9606
591 3CM9 3 L, M, N, O Immunoglobulin light chain 9606
592 3CHN 1 L, M, N, O Immunoglobulin kappa light chain 9606
593 2QTJ 1 L, M, N, O Kappa light chain IgA1 9606
594 2ESG 1 L, M Immunoglobulin A1 light chain 9606
595 1R70 1 A, C Human IgA2(m1) Light Chain 9606
596 1IGA 2 C, D IGA1 CHAINS A AND B, HEAVY, CHAINS C AND D, LIGHT 9606